Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon Mar 27, 2019 10:30am
123 Views
Post# 29542003

GREAT NEWS...THANKS DR. REID...

GREAT NEWS...THANKS DR. REID...

 

Diagnos signs MOU with U.S. hospital for Cardio

 

2019-03-27 10:08 ET - News Release

 

Dr. Reid Maclellan reports

DIAGNOS ANNOUNCES MEMORANDUM OF UNDERSTANDING WITH ONE OF THE 5 LARGEST HOSPITALS IN THE US FOR THE FINAL DEVELOPMENT OF ITS CARDIO APPLICATION

Diagnos Inc. has signed a memorandum of understanding to establish a framework between one hospital in the United States and Diagnos.

Under the terms of a mutual non-disclosure agreement, the name of the hospital can't be disclosed. The hospital is engaged and specializes in the medical field of stroke and related cardiological issues. The hospital has one of the largest databases in the world for stroke related patients. Diagnos will utilize this database to finalize the development and validation for Cardio.

Cardio is an application that predicts the future risk of a patient having a stroke or other conditions that may lead to a stroke. "We are honored to form this relationship with a hospital and team of clinicians that are truly experts in the field of stroke. Using our FL AI RE platform we are able to analyse the retina and derive the key features that predict a stroke. Having access to the thousands of medical records from our hospital partner will enable Diagnos to finish the development and testing of the application. The screening will be done with the same commercial fund us camera used for identifying retinopathy with diabetic patients," commented Dr. Reid Maclellan, director at Diagnos.

The Corporation is also announcing that a new date of April 10th, 2019 has been fixed for the meeting of the Debentureholders initially scheduled for April 4th, 2019 as stated in the Corporate Reorganization press release of March 11th, 2019. The decision of rescheduling the meeting date to April 10th, 2019 was undertaken to allow the Corporation to efficiently comply with the mailing of meeting material requirements.

About Diagnos

Bullboard Posts